跳至主要内容
临床试验/NCT02830243
NCT02830243已完成3 期

The Comparison of Analgesic Effect of Volatile Anesthetics Using Surgical Pleth Index

Kangbuk Samsung Hospital1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2016年7月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
Remifentanil consumption (µg/kg/min)

研究概览

简要总结

The purpose of this clinical trial is to compare analgesic effect of sevoflurane and desflurane at equal minimum alveolar concentrations using surgical pleth index.

详细描述

Volatile anesthetics vary in their relative hypnotic potency. Recent studies demonstrated that equi-minimum alveolar concentration of various volatile anesthetic agents may produce different bispectral index values. However, the difference between analgesic effects of volatile anesthetics have not yet been investigated. The purpose of this clinical trial is to compare analgesic effect of sevoflurane and desflurane at equal minimum alveolar concentrations using surgical pleth index-guided remifentanil infusion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients undergoing balanced general anesthesia using volatile anesthetics and remifentanil
  • patients with american society of anesthesiologist physical status I, II
  • patients aged 19-65 years
  • patients obtaining written informed consent

排除标准

  • patients with a history of any psychiatric or neurological disease
  • patients who had received any medication affecting the central nervous system
  • patients who had received medication affecting the sympathetic or parasympathetic nervous systems
  • patients undergoing tracheal intubation for airway management
  • pregnant women

研究组 & 干预措施

Sevoflurane

Experimental

Anesthesia was maintained with sevoflurane.

干预措施: Sevoflurane (Drug)

Desflurane

Experimental

Anesthesia was maintained with desflurane.

干预措施: Desflurane (Drug)

结局指标

主要结局

Remifentanil consumption (µg/kg/min)

时间窗: During the intraoperative period

次要结局

  • Target effective site concentration of remifentanil (ng/ml)(After at least 10 min of stable surgical pleth index values)

研究者

发起方
Kangbuk Samsung Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kyoungho Ryu

Clinical assistant professor

Kangbuk Samsung Hospital

研究点 (1)

Loading locations...

相似试验